Alnylam releases promising data on rare disease drug
September 27, 2018 at 07:00 AM EDT
"We have an incredible amount of confidence that the drug does what it’s meant to do," Alnylam General Manager Akin Akinc said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|